QDEL
QuidelOrtho Corporation Common Stock
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Best Diagnostics Stocks 2026 →
QuidelOrtho (QDEL) Stock: Buy, Sell, or Hold?
$11.52
-0.57 (-4.71%)
▼
5d:
-18.24%
30d:
-13.06%
90d:
-22.32%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 03, 2026
0d
Protect QDEL Gains
Updated Nov 10, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (78%)
Quality Score
42/100
Position
OVERSOLD
30-Day Fair Range
$12.15 – $14.13
Position: OVERSOLD
Forward P/E & Valuation
8.8x
FAIR
vs 7.9x historical avg
Wall Street Target
$15.00
+30.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$10.41 / $14.85
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: QDEL is down 18.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When QDEL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$20.24
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$12.57
8.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: QDEL is currently trading at $11.52, which is considered oversold relative to its 30-day fair value range of $12.15 to $14.13. From a valuation perspective, the stock is trading at a premium (Forward PE: 8.8) compared to its historical average (7.9). At these levels, the market is pricing in 3.5% annual earnings growth.
Technical Outlook: Technically, QDEL is in a strong downtrend. Immediate support is located at $10.41, while resistance sits at $14.85. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $15.00 (+30.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, QDEL is in a strong downtrend. Immediate support is located at $10.41, while resistance sits at $14.85. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $15.00 (+30.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$12.15 -
$14.13
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.1%
Trading Range & Key Levels
30-Day Trading Range
$12.15 -
$14.13
Current vs Trading Range
OVERSOLD
Support Level
$10.41
Resistance Level
$14.85
Current Trend
Strong Downtrend
Technical data as of
Nov 10, 2026
Protect Your Profits
Holding QDEL? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.7%)
- BULLISH: Trading 30.2% below Wall St target ($15.00)
- BULLISH: Expecting earnings turnaround to 3.5% growth with -11.6% revenue growth
- WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
8.76
Wall Street Target
$15.00
(+30.2%)
Revenue Growth (YoY)
-11.6%
Earnings Growth (YoY)
-77.1%
Profit Margin
-14.2%
Valuation Premium vs History
+3.5% premium
PE vs Historical
8.8 vs 7.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.5%
(market-implied from PE analysis)
1-Year Target
$11.92
(+4%)
2-Year Target
$12.34
(+7%)
3-Year Target
$12.77
(+11%)
3-Yr Target (if PE normalizes)
(PE: 9→8)
PE COMPRESSION
$11.52
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 97.3%)
$88.17
(+665%)
Base:
(SPY PE: 8.8, Growth: 97.3%)
$38.88
(+238%)
Bear:
(PE: 7.4, Growth: 97.3%)
$33.05
(+187%)
Share QDEL Analysis
Share this live QDEL analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (QDEL)
Bearish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 4, 2026
Daily AI digest
AI Retail Discussion Summary:
QuidelOrtho (QDEL) reported Q3 2026 earnings, missing revenue estimates and lowering full-year revenue and EPS guidance. Stock dropped 10.6% in response.
Key Retail Themes:
earnings miss
lowered guidance
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 5:32 AM ET
Data refreshes hourly during market hours. Next update: 6:32 AM
Data refreshes hourly during market hours. Next update: 6:32 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QDEL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EW
Edwards Lifesciences Corp |
STRONG BUY
30 analysts |
$112 | 42 HOLD |
|
BSX
Boston Scientific Corp |
BUY
31 analysts |
$50 | 53 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$119 | 37 SELL |
|
MDT
Medtronic PLC |
BUY
30 analysts |
$105 | 35 SELL |
|
PODD
Insulet Corporation |
BUY
26 analysts |
$178 | 43 HOLD |
Advanced QDEL Option Strategies
Professional options setups generated by AI based on today's QDEL price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive QDEL Research Pages
